Ledipasvir/sofosbuvir and ribavirin for the treatment of ribavirin-refractory persistent hepatitis E virus infection

Persistent Hepatitis E Virus infection (HEV) is a rare but increasingly recognised condition in immunocompromised individuals. Untreated, this infection can rapidly progress to cirrhosis. Ribavirin is recommended as the first line treatment and the majority achieve sustained viral clearance. However...

全面介紹

書目詳細資料

發表在:	IDCases
Main Authors:	Jennifer Gallacher, Yusri Taha, Ana da Silva Filipe, Samreen Ijaz, Stuart McPherson
格式:	Article
語言:	英语
出版:	Elsevier 2023-01-01
主題:	Hepatitis E virus Treatment Antiviral resistance Chronic infection Immunosuppressed
在線閱讀:	http://www.sciencedirect.com/science/article/pii/S2214250923000653